GLP-1 Supplements: Do Berberine, Lemon Extract and Probiotics Work?

Mostly, no. Supplements sold as “GLP-1” products do not contain GLP-1 or anything that acts like the drugs. Their ingredients either have not been shown to cause weight loss in people, or cause very little: the best-studied, berberine, averaged 0.88 kg more weight lost than control in a 2026 pooling of 23 trials.^[1] Semaglutide’s main trial produced 12.7 kg more than placebo.^[13] And a few lemon-extract trials do show a measured GLP-1 rise, in which the people taking it lost no weight.^[5]

What a GLP-1 supplement actually is

GLP-1 is a gut hormone your body releases when you eat. Wegovy, Ozempic and Zepbound are lab-made versions engineered to last for days. A “GLP-1 supplement” is neither. It is a capsule, powder, gummy or drop containing plant extracts, fiber or bacteria, marketed on the idea that it nudges your own gut to release a little more of the hormone.

Most products in the category draw on the same short list of ingredients:

• Berberine, a plant alkaloid, often promoted online as “nature’s Ozempic”.^[4]
• Lemon flavonoid extract (eriocitrin, sold under the ingredient brand Eriomin), the core of several branded daily “GLP-1” capsules.
• Saffron extract, sold for appetite and snacking.
• Probiotics, including Akkermansia muciniphila and multi-strain blends, sold as raising GLP-1 through the gut microbiome.
• Fiber such as psyllium or glucomannan, and minerals such as chromium.

Because they are sold as dietary supplements, none of them went through FDA review before sale. Under the 1994 supplement law, FDA states that it “is not authorized to approve dietary supplements for safety and effectiveness before they are marketed.”^[16] The evidence below is whatever independent and company researchers chose to publish.

The ingredients, one by one

Berberine: a real effect, and a small one

Berberine is the only ingredient in the category with enough trials to pool, and the pooled answer has shrunk as trials have accumulated. A 2020 meta-analysis of 12 studies put the weight effect at 2.07 kg.^[2] A 2026 analysis of 23 articles, using a formal risk-of-bias tool, put it at 0.88 kg, with a confidence interval running from 0.39 to 1.36 kg.^[1] Its authors asked future trials to report the purity and dose of the berberine actually given, and to fix “lack of blinding and randomization,” which tells you something about the trials it was built from.^[1]

The GLP-1 part of the berberine story comes from animals and cells. The study usually cited found berberine raised GLP-1 release in rats and in a human intestinal cell line grown in a dish.^[3] No randomized trial in people has shown that the weight effect, such as it is, runs through GLP-1.

Berberine is also not inert. A 2026 review of its drug interactions describes it as acting on the liver enzymes CYP3A4, CYP2D6 and CYP2C9 and on drug transporters, with the clearest human example a 34.5% rise in cyclosporine exposure in kidney-transplant patients.^[4] The authors concluded it should be handled as an active drug in anyone taking prescriptions, and warned about people self-treating with it now that GLP-1 drugs are in the news.^[4] If you take blood thinners, diabetes drugs, transplant drugs or anything with a narrow safe dose range, ask a pharmacist before starting it. Our drug interaction checker covers the prescription side.

Lemon flavonoid: GLP-1 went up, weight did not

Of everything on this list, this ingredient has the strongest case for the “raises GLP-1” label, and its own trials show why that label is not a weight-loss claim. In a 12-week trial of 103 adults with prediabetes, all three doses (200, 400 and 800 mg) raised GLP-1 by about 15% and nudged blood sugar down about 5%. The paper also reports that the extract “did not influence the anthropometric and dietary variables”: no change in weight or measurements, and no change in what people ate.^[5]

A smaller crossover trial in 30 people with high blood sugar found the same pattern: GLP-1 up 17%, glucose down 5%, and other measures, including body measurements, unchanged.^[6] Both trials were small and short, and both were run by the same research group. Read honestly, they suggest a modest blood-sugar effect in people with prediabetes. They are not evidence that the extract helps anyone lose weight.

Saffron: no weight effect across 25 trials

A 2022 meta-analysis pooled 25 randomized trials of saffron in people with overweight or obesity. Weight fell by 0.32 kg more than control, which was not statistically significant (p = 0.82), and BMI, waist and hip measurements did not change either. Only waist-to-hip ratio moved.^[7] Saffron is sold for snacking and mood as well as weight, and those claims have their own literature, but on the scale the pooled result is flat.

Probiotics: the endpoints that were tested

The best-run Akkermansia trial, 142 adults with metabolic syndrome over four months, missed its primary endpoint. A larger GLP-1 rise after a sugar drink turned up only in analyses run afterward, and weight loss in the most favorable subgroup did not reach significance (p = 0.06).^[8] We walk through that trial in the supplement that missed its endpoint.

The other trial often cited for a “GLP-1 probiotic” tested a five-strain blend in 76 people with type 2 diabetes for 12 weeks. Its primary result was a smaller blood-sugar rise after a test meal, at p = 0.0500, exactly on the line, and every author was an employee and shareholder of the company that makes the blend.^[9] It did not set out to measure weight or GLP-1, and the authors themselves called it a proof of concept needing confirmation. For what GLP-1 drugs themselves do to gut bacteria, see GLP-1 drugs and the gut microbiome.

Why a small GLP-1 rise is not a small dose of Ozempic

The marketing rests on an equation: the drugs work through GLP-1, this raises GLP-1, so this works a bit like the drugs. The equation breaks on time.

Your own GLP-1 is destroyed almost as soon as it is made. An enzyme called DPP-4 begins breaking it down before the hormone has even left the gut,^[10] and what reaches the bloodstream has a half-life of one to two minutes.^[11] That speed is the reason drug companies could not simply give people the natural hormone: it vanished too fast to be useful as a medicine.^[11]

Semaglutide was built to get around exactly that. It latches onto albumin circulating in the blood, which shields it from breakdown, and its half-life is about one week. The Wegovy label says it remains in circulation for five to seven weeks once dosing stops.^[12] So a drug-treated body has GLP-1 receptors stimulated around the clock, at levels a meal never reaches. A supplement that lifts the natural after-meal spike by 15%, as the lemon-extract trial measured,^[5] is still adding to a signal that lasts minutes. That is the gap between a 0 kg result and a 12.7 kg one.

The same arithmetic applies to food. Protein, fiber and meal order really do change the natural GLP-1 response, and our page on foods that boost GLP-1 naturally covers what that is worth. It is worth eating well, not swapping for a prescription.

What a supplement is allowed to claim

A supplement label is allowed to make “structure/function” claims, with “supports healthy metabolism” the classic example, as long as it also prints the disclaimer most shoppers have seen on the back of a bottle:^[14]

This statement has not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

— 21 CFR 101.93, required supplement disclaimer

A label that makes a disease claim instead turns the product into a drug in the eyes of the law, and an unapproved one.^[14]

Where weight sits in that line was settled in 2000. FDA wrote that “obesity is a disease, and that obesity claims are not acceptable structure/function claims,” while ordinary overweight is not a disease.^[15] So a supplement may say it supports weight loss but may not say it treats obesity. The rule also treats as a disease claim any statement that a product “is a substitute for a product that is a therapy for a disease.”^[14] FDA’s own example of that, in the same rulemaking, was the label “Herbal Prozac.”^[15] Marketing that calls a capsule a natural Ozempic is built on the same idea.

Advertising is policed separately, by the FTC, and its bar is higher than the label rules. The FTC’s health-products guidance says health benefits generally need to be backed by “randomized, controlled human clinical testing,” warns that after-the-fact analyses that depart from a study’s plan are not reliable support, and says the FDA disclaimer “won’t cure an otherwise deceptive ad.”^[19] Measured against that, a GLP-1 rise in a 30-person trial, or a subgroup found after the main endpoint failed, does not support a weight-loss promise.

What regulators have actually done

Very little so far, aimed at supplements. Federal GLP-1 enforcement has mostly targeted compounded and “research use” injectables, which we track in our FDA warning letter register. Two letters touch the supplement side:

• Veronvy, December 2024. FDA found that the “Elily Veronvy” metabolic drops, sold with a section headed “The Science of GLP-1,” were unapproved new drugs. The site claimed users lost “up to 52 pounds in 3 months during clinical trials” and showed an “FDA APPROVED” seal; FDA said no approval existed and called the products misbranded.^[17]
• Guangzhou Huli Technology (Fantasy Face), March 2026. FDA treated a “GLP-1 Weight Control Oral Solution” sold through an eBay store as an unapproved new drug, citing listing claims as plain as “Metabolism Support . . . Weight management Blood Sugar Balance.” The letter does not say what the product contained.^[18]

We found no FTC case brought against a GLP-1-branded supplement to date. A separate, older risk applies to the whole weight-loss aisle: FDA keeps a running list of products sold as supplements that it found contained hidden drug ingredients, which it says are “likely to be contaminated with dangerous hidden ingredients,” with new entries as recently as September 2026.^[20]

How to read a GLP-1 supplement label

1. Find the ingredient, not the brand. “GLP-1” on the front is a marketing word. The Supplement Facts panel tells you whether you are buying berberine, a lemon extract, saffron, fiber or bacteria, and each has the evidence above.
2. Ask what the cited study measured. “Clinically shown to increase GLP-1” and “clinically shown to cause weight loss” are different claims. The lemon-extract trials support the first and contradict the second.^[5]
3. Check for the disclaimer. A product that claims to treat obesity or diabetes, or says it is FDA approved, is making claims the rules forbid for a supplement.^[14][17]
4. Treat berberine like a medicine. Tell your prescriber or pharmacist, especially if you take diabetes, transplant or heart drugs.^[4]
5. Do not stack it on a GLP-1 drug expecting more. Nothing in the trials here tested these ingredients alongside semaglutide or tirzepatide.

If a product sells itself as a needle-free GLP-1 through the skin, the problem is the size of the molecule, which we explain in do GLP-1 patches work. For graded entries on berberine, fiber and other weight-loss supplements, see the supplement evidence grader. If what you want is the drug itself, brand names vs molecules sorts out which product is which.